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COMMUNICATION  FROM  THE  COMMISSION  TO  THE  EUROPEAN  PARLIAMENT 
pursuant  ~o Article  149.2(b)  of  the  EEC  Treaty 
Common  positions  of  the  :ouncil  on  two  proposals 
relating  to  veterinary medicinal  products. 
Proposal  for  a  Council  Directive  aaending  Directive 
81/851/EEC  on  the  approxiaation of  the  laws  of  the  Meaber 
States  relating  to veterinary aedicinal  products  (SYN  189)· 
Proposal  for  a  Council  Directive extending  the  scope  of 
Directive  81/851/EEC  on  the  approxiaation of  the  laws  of 
the  Me•ber  States  relating  to  veterinary aedicinal  products 
and  laying  down  additional  provisions  for  ia•unological 
veterinary aedicinal  products  (SYN  190). Subject 
... ·· 
COMMUNICATION  OF  THE  COMMISSION  TO  THE  PARLIAMENT 
Common  positions  of  the Council  on·  two  proposals 
relating  to  veterinary  medicinal  products. 
On  10  January  1989,  the  Commission  transmitted  to  the  Council 
a  package  of  proposals  relating  to  veterinary  medicinal 
products  <COM  (88)  779  final),  including  two  coming  under  the 
scope  of  the  cooperation  procedure; 
a)  a  proposal  (9r  a  Council  Directive  amending  Directive 
81/851/EEC  on  the  approximation  of  the  laws  of  the  Member 
States  ~elating  to  veterinary.medicinal  products  (SYN  189); 
b)  a  proposal  for  a  Council  Directive  extending  the  scope  of 
Directive  81/851/EEC  on  the  approximation  of  the  laws  of 
the  Member  States  relating  to  veterinary  medicinal  products 
and  laying  down  additional  provisions  for  immunological 
v~terinary medicinal  products  (SYN  190). 
Following  the  opinions  of  the  European  Parliament,  given  on 
March  1990,  the  Commission  amended  the  two  proposals  on  26 
April  1990  (COM  (90)  135  final). 
On  26  June  1990,  the  Council  adopted  common  positions  in 
respect  of  the  two  proposals. 
The  main  points  on  which  the  Council's  common  positions  differ 
from  the  Commission  proposal  are  outlined  below. - 2  -
. 1..  Propos.al .for· a,Council  Direetive aaendin!FDfreeti¥e 
·.  81/&51/EEC  ~n, the  approxiaat ion  of  the  laws  tJf  t·he  Pfeaber 
States :relating  to veterinary aedic inal  products  (·SYH  l 89  ). ; 
LI  Scope  of  the  Directive  (Article  Ul)) 
Because  of  fears  of  creating  a  legal  vacuum  b~tween 
Directive  81/851/EEC  and  Directive  70/524/EEC  on  additives 
for  animal  feedingstuffs,  the  Council  has  not  accepted  the 
proposal  in  Article  1(1)  to  amend  the  definition of  a 
veterinary  medicinal  product .. Instead,  in  a  minutes 
statement,  the  Commission  is  requested  to  take  whatever 
measures  necessary  to  clarify  the  borderline  between  the 
two  directives. 
1.2  Substances  u~ed  in  ~et~rinary  medici~al products  subject 
to special  crintrols  (Art.  1(2)) 
The  Council  has  changed  the  drafting  of  this  amendment  to 
Article  1(5)  of  Directive  81/851/EEC  in  order  to  clarify 
the  list of substances  to  be  subject  to  special  controls. 
For  drafting  reasons,  the  last  sub-paragraph  has  be•n 
transferred  to  Article  52. 
1.3  Marketing .authorization  for  veterinary  medicin~l products 
(Article  1(4)) 
A  number  of  detailed  changes  have  been  made  to  this 
amendment  to  Article  4  of  Directive  81/851/EEC,  in  order 
to: 
- specify  the  conditions  under  which  Member  States  may 
grant  emergency  marketing  authorizations; 
- clarify  the  criteria according  to  which  veterinary 
medicines  are  to be  available  on  prescription  only; 
- clarify  the  scope  of  the  exception  allowing  for  the 
conduct  of  clinical  trials; 
- restrict  the  circumstances  under  which  veterinari~ns  may 
have  recourse  to  non-authorized  medicinal  product~  in 
order  to  treat  animals  under  their  care~ 
prov-ide  for .proper: control ·Of  veterinarians  providing 
trans-frontier  services; 
.:  •• r'" 
··~·. 
...  :~·  .:,  . .. , . ..  .... 
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1. 4  Documentation  accompanying  applications  fo~ authorization 
<Article  1  (5)) 
The  Council  h~s  changed  paragraph  8  of  this  amendment  to 
Article  5  of  Directive  81/851/EEC  in  order  to  require 
applicants  to  submit  details  of  a  routine  method  of 
analysis  which  can  be  used  by  the  public  authorities  to 
detect  residues.  A  new  paragraph  9a  in  Article  1  of  the 
proposal  requires  the  applicant  to  submit  an~-.samples 
necessary  for  the  verification of  the  method,  and  a  new 
paragraph  in  Article  1  (10)  provides  for  the  updating  of 
the  method,  when  necessary. 
In  addition,  the  Council  has  amended  paragraph  10, 
concerning  the  duration  of  the  peri9d·of  protection  to  be 
given  to  the  manufariturers  of  ~nnovatory products  in  order 
to  align veterinary  medicih~s  legislatio~ with  the  rules 
laid  down  for  medicinal  produc-ts  for  human  use  in  Article 
4  point  8  of  Directive  65/65/EEC  as  amended  by  Directive 
87/21/EEC. 
1.5  The  Committee  for  Veterinary  Medicinal  products  (Article 
1 (11) 
The  Council  has  extended  the  scope  of  the  amendments 
proposed  to  Article  16  concerning  the  publication  of 
details  of  the  members  of  the  CVMP  and  the  maintenance  of 
a  register of  interests,  to  cover  the  case  of  experts  who 
.may  attend  CVMP  meetings  on  an  occasional  basis,  but  are 
not  members  of  the  Committee. 
Bearing  in  mind  that  the  Commission  is  expected  to  bring 
forward  comprehensive  proposals  shortly  for  the 
establishment  of  a  future  system  for  the  authorization  of 
medicinal  products  in  the  Community  and  for  the 
establishment  of  a  European  Medicines  Evaluation  Agency, 
the  Council  has  deleted  the  proposed  amendment  to  Article 
22  (3)  of  Directive  81/851/EEC  which  would  have  made 
compliance  with  CVMP  opinions  compulsory  for  Member  States 
and  has  aligne~ the  procedure  on  the  corresponding 
provisions  of  Directiv~ 75/319/EEC  as  amended  by  Directive 
83/570/EEC  relating  to  medicinal  products  for  human  use. 
1.6  Veterinary medicinal  products  in  transit  (Article  1  (l2a•) 
The  Council  has  inserted  a  new  clause  to  ensure  the 
appropriate  supervision  of  veterinary  medicinal  products 
in  transit. h.  1.7,Vete.rinar,y:.pharllacovigilance  (Article  1  fl7a)> ,, 
~~·  .:A,new,pa~agraph_l7a has  bee~ inserted  in-Article~)  to 
encourage  the  reporting  of  adverse  reactions  to. veterinary 
medicines  by  veterinarians.  · 
l .8  Supervision  of  distribution  <Article  1  (18)) 
The  terms  of  Article  39  of  Directive  81/851/EEC  have  been 
amended  to  require  Member  states  to  exchange  the 
information  necess.ary  to  ensure  that  the  new  distribution 
requir~ments  c~ntained in  Chapter  VJII  of  the  Directive 
are  complied  with. 
1.9  Labelling  of  veterinary  medicinal  products  <Article  1  (20)) 
The  drafting  of this amendment  to  Article  43  of  Directive 
81/851/EEC  has  been  changed  to  align  it  with  the 
corresponding  provisions  relating  to  medicinal  products 
for  human  use. 
1.10  Package  leaflets  (Article  l  (21)) 
A minor  drafting  change  has  been  made  to  clarify  the 
linguistic  requirements  for  package  leaflets. 
1.11  Distribution of  veterinary  medicinal  products  <Article  I  (22)) 
Although  the  Council  has  accepted  the  principles  underlying 
the  proposal  to  insert  a  new  Chapter  in  Directive 
81/851/EEC  dealing  with  controls  on  the  distribution  of 
veterinary  medicinal  products,  the  Council  has  made  a 
number  of  detailed  changes  in  order  to  strike  the  correct 
balance  between  ensuring  appropriate  controls  on  veterinary 
distribution,  but  avoidung  unnecessarily  ~nerous  record 
k~eping requirements.  In  addition,  the  Council  has  inserted· 
a  new  Article  covering  record  keeping  requirements  for· 
farmers. 
Although  _it  considered  that  it was  not  possible,  at-
pre~ent,  to  adopt  ~greed Community  lists-of medicines 
-a~ailabl~ with-or  wit~out prescription,  in ·a  minutes· 
statement,  the  Cotincil  has  requested  the_C~~missio~ to 
cpnsider  this  as  a  matt~~ of  urgency,  on~e it  has  iec~ived 
the  necessary  inform~tion  from  the  Member  Sta~es.  · 
.  The  Commission  can  acc~pt  the  Council's  common  position. ..  -·  :>  - I  - ., 
2.  Proposal  for-a  Council  Directive extending  the  scope  of 
Directive  81/851/EEC  on  the  approxi•ation of  the  laws  of 
the  Member  States  relating  to  veterinary •edicinal  products 
and  laying  down  additional  provisions  for  i••unological 
veterinary •edicinal  products  (SYN  190). 
2.1  Autogenous  vaccines 
The  Council  has.altered  th~  terms  of  Article  1(3)  to 
allow  Member  States  to  exempt  non-inactivated 
autogenous  vaccines,  which  are  not  traded  within  the 
Community  from  the  requirement  to  obtain  authorization. 
2.2  Batch  testing  of  immunological  veterinary  medicines 
The  Council  has  changed  the  terms  of  Article  3(3)  in 
order  to  allow  Member  states  to  carry  out  further  tests 
on  batches  of  products  which  have  already  tested  in  one 
Member  State,  if  these  additional  tests  are  necessary 
because  of  differences  in  veterinary  conditions.  In 
order  to  ensure  that  this  provision  is  not  abused,  the 
Commission  is  to  be  informed  each  time  additional  tests 
are  required. 
2.3  Restrictions  on  the  use  of  immunological  veterinary 
medicines 
For  drafting  reasons,  the  Council  has  merged  the  text 
of  subparagraphs  (a)  and  (c). 
2.4  Application  of  the  Directive  to  existing  products 
Because  of  the  very  large  number  of  products  to  be 
reviewed,  in  excess  of  500  in  certain  Member  States, 
the  Council  has  extended  the  time  limit  for  the 
application  of  the  Directive  ~o existing  products  from· 
3  to  5  years. 
The  Commission  can  accept  the  Council's  common  position. 